About this Journal Submit a Manuscript Table of Contents
International Journal of Rheumatology
Volume 2011 (2011), Article ID 728471, 6 pages
http://dx.doi.org/10.1155/2011/728471
Review Article

Cardiopulmonary Manifestations of Ankylosing Spondylitis

1Rheumatology Division, The George Washington University Medical Center, 2150 Pennsylvania Avenue, 3-416 NW, Washington, DC 20037, USA
2Internal Medicine Division, The George Washington University Medical Center, Washington, DC 20052, USA

Received 20 November 2010; Revised 21 January 2011; Accepted 9 February 2011

Academic Editor: Kenneth C. Kalunian

Copyright © 2011 Mahnaz Momeni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Moyssakis, E. Gialafos, V. A. Vassiliou et al., “Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis,” Scandinavian Journal of Rheumatology, vol. 38, no. 3, pp. 216–221, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. A. Yildirir, S. Aksoyek, M. Calguneri, A. Oto, and S. Kes, “Echocardiographic evidence of cardiac involvement in ankylosing spondylitis,” Clinical Rheumatology, vol. 21, no. 2, pp. 129–134, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Caliskan, D. Erdogan, H. Gullu et al., “Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis,” Atherosclerosis, vol. 196, no. 1, pp. 306–312, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. B. H. Bulkley and W. C. Roberts, “Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients,” Circulation, vol. 48, no. 5, pp. 1014–1027, 1973. View at Scopus
  5. C. A. Roldan, J. Chavez, P. W. Wiest, C. R. Qualls, and M. H. Crawford, “Aortic root disease and valve disease associated with ankylosing spondylitis,” Journal of the American College of Cardiology, vol. 32, no. 5, pp. 1397–1404, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Kaźmierczak, M. Peregud-Pogorzelska, J. Biernawska, et al., “Cardiac arrhythmias and conduction disturbances in patients with ankylosing spondylitis,” Angiology, vol. 58, no. 6, pp. 751–756, 2008. View at Publisher · View at Google Scholar · View at PubMed
  7. V. K. Dik, M. J. L. Peters, P. A. Dijkmans et al., “The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis,” Scandinavian Journal of Rheumatology, vol. 39, no. 1, pp. 38–41, 2010. View at Publisher · View at Google Scholar · View at PubMed
  8. A. Yildirir, S. Aksoyek, M. Calguneri et al., “QT dispersion as a predictor of arrhythmic events in patients with ankylosing spondylitis,” Rheumatology, vol. 39, no. 8, pp. 875–879, 2000.
  9. E. Toussirot, M. Bahjaoui-Bouhaddi, J. C. Poncet et al., “Abnormal autonomic cardiovascular control in ankylosing spondylitis,” Annals of the Rheumatic Diseases, vol. 58, no. 8, pp. 481–487, 1999.
  10. A. Yildirir, S. Aksoyek, M. Calguneri et al., “No evidence of cardiac autonomic involvement in ankylosing spondylitis, as assessed by heart rate variability,” Clinical Rheumatology, vol. 20, no. 3, pp. 185–188, 2001.
  11. B. A. Gould, J. Turner, D. H. Keeling, P. Hickling, and A. J. Marshall, “Myocardial dysfunction in ankylosing spondylitis,” Annals of the Rheumatic Diseases, vol. 51, no. 2, pp. 227–232, 1992.
  12. M. J. L. Peters, I. Visman, M. M. J. Nielen et al., “Ankylosing spondylitis: a risk factor for myocardial infarction?” Annals of the Rheumatic Diseases, vol. 69, no. 3, pp. 579–581, 2010. View at Publisher · View at Google Scholar · View at PubMed
  13. H. Divecha, N. Sattar, A. Rumley, L. Cherry, G. D. O. Lowe, and R. Sturrock, “Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation,” Clinical Science, vol. 109, no. 2, pp. 171–176, 2005. View at Publisher · View at Google Scholar · View at PubMed
  14. S. Heeneman and M. J. A. P. Daemen, “Cardiovascular risks in spondyloarthritides,” Current Opinion in Rheumatology, vol. 19, no. 4, pp. 358–362, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. F. Brunner, A. Kunz, U. Weber, et al., “Ankylosing Spondylitis and Heart Abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population?” Clinical Rheumatology, vol. 25, pp. 24–29, 2005.
  16. C. Dunham and F. Kautz, “Sondylarthritis Ankylopoietica, A Review and Report of Twenty Cases,” The American Journal of the Medical Sciences, vol. 201, pp. 232–250, 1941.
  17. S. Baser, S. Cubukcu, S. Ozkurt, N. Sabir, B. Akdag, and E. Diri, “Pulmonary involvement starts in early stage ankylosing spondylitis,” Scandinavian Journal of Rheumatology, vol. 35, no. 4, pp. 325–327, 2006. View at Publisher · View at Google Scholar · View at PubMed
  18. E. C. Rosenow, C. V. Strimlan, J. R. Muhm, and R. H. Ferguson, “Pleuropulmonary manifestations of ankylosing spondylitis,” Mayo Clinic Proceedings, vol. 52, no. 10, pp. 641–649, 1977.
  19. I. P. Casserly, H. M. Fenlon, E. Breatnach, and S. M. Sant, “Lung findings on high-resolution computed tomography in idiopathic ankylosing spondylitis-correlation with clinical findings, pulmonary function testing and plain radiography,” British Journal of Rheumatology, vol. 36, no. 6, pp. 677–682, 1997.
  20. P. D. Sampaio-Barros, E. M. F. P. Cerqueira, S. M. Rezende et al., “Pulmonary involvement in ankylosing spondylitis,” Clinical Rheumatology, vol. 26, no. 2, pp. 225–230, 2007. View at Publisher · View at Google Scholar · View at PubMed
  21. K. Turetschek, W. Ebner, D. Fleischmann, et al., “Early pulmonary involvement in ankylosing spondylitis: assessment with Thin-section CT,” Clinical Radiology, vol. 33, pp. 632–636, 2000.
  22. N. Kanathur and T. Lee-Chiong, “Pulmonary Manifestations of Ankylosing Spondylitis,” Clinics in Chest Medicine, vol. 31, no. 3, pp. 547–554, 2010. View at Publisher · View at Google Scholar · View at PubMed
  23. W. M. Rumancik, H. Firooznia, M. S. Davis Jr., et al., “Fibrobullous disease of the upper lobes: an extraskeletal manifestation of ankylosing spondylitis,” Journal of Computed Tomography, vol. 8, no. 3, pp. 225–229, 1984.
  24. A. K. Sil, “Lung changes in ankylosing spondylitis,” Chest, vol. 61, no. 4, pp. 406–407, 1972.
  25. D. Davies, “Lung fibrosis in ankylosing spondylitis,” Thorax, vol. 27, no. 2, p. 262, 1972.
  26. D. Thai, R. S. Ratani, S. Salama, and R. M. Steiner, “Upper lobe fibrocavitary disease in a patient with back pain and stiffness,” Chest, vol. 118, no. 6, pp. 1814–1816, 2000. View at Publisher · View at Google Scholar
  27. B. A. Scobie, “The lungs in ankylosing spondylitis,” British Medical Journal, vol. 4, pp. 492–493, 1971.
  28. C. K. Tan, C. C. Lai, C. H. Chou, and P. O. R. Hsueh, “Mycobacterium celatum pulmonary infection mimicking pulmonary tuberculosis in a patient with ankylosing spondylitis,” International Journal of Infectious Diseases, vol. 13, no. 6, pp. e459–e462, 2009. View at Publisher · View at Google Scholar · View at PubMed
  29. W. P. U. Kennedy, L. J. Milne, W. Blyth, and G. K. Crompton, “Two unusual organisms, Aspergillus terreus and Metschnikowia pulcherrima, associated with the lung disease of ankylosing spondylitis,” Thorax, vol. 27, no. 5, pp. 604–610, 1972.
  30. H. H. Ho, M. C. Lin, K. H. Yu, C. M. Wang, Y. J. J. Wu, and J. I. Y. Chen, “Pulmonary tuberculosis and disease-related pulmonary apical fibrosis in ankylosing spondylitis,” Journal of Rheumatology, vol. 36, no. 2, pp. 355–360, 2009. View at Publisher · View at Google Scholar · View at PubMed
  31. L. T. Tanoue, “Pulmonary involvement in collagen vascular disease: a review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, Sjögren's syndrome, and relapsing polychondritis,” Journal of Thoracic Imaging, vol. 7, no. 2, pp. 62–77, 1992. View at Publisher · View at Google Scholar
  32. A. A. Cohen, E. A. Natelson, R. E. Fechner, et al., “Fibrosing interstitial pneumonitis in ankylosing spondylitis,” Chest, vol. 59, no. 4, pp. 369–371, 1971.
  33. A. S. Souza, N. L. Müller, E. Marchiori, L. V. Soares-Souza, and M. De Souza Rocha, “Pulmonary abnormalities in ankylosing spondilitis: inspiratory and expiratory high-resolution CT findings in 17 patients,” Journal of Thoracic Imaging, vol. 19, no. 4, pp. 259–263, 2004. View at Publisher · View at Google Scholar
  34. U. Dincer, E. Cakar, M. Z. Kiralp, E. Bozkanat, H. Kilac, and H. Dursun, “The pulmonary involvement in rheumatic diseases: pulmonary effects of ankylosing spondylitis and its impact on functionality and quality of life,” Tohoku Journal of Experimental Medicine, vol. 212, no. 4, pp. 423–430, 2007. View at Publisher · View at Google Scholar
  35. A. El Maghraoui, S. Chaouir, A. Abid et al., “Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing,” Clinical Rheumatology, vol. 23, no. 2, pp. 123–128, 2004. View at Publisher · View at Google Scholar · View at PubMed
  36. C. C. Lee, S. H. Lee, I. J. Chang et al., “Spontaneous pneumothorax associated with ankylosing spondylitis,” Rheumatology, vol. 44, no. 12, pp. 1538–1541, 2005. View at Publisher · View at Google Scholar · View at PubMed
  37. H. Kaneda, Y. Saito, M. Okamoto, T. Maniwa, K. I. Minami, and H. Imamura, “Bilaterally repeated spontaneous pneumothorax with ankylosing spondylitis,” General Thoracic and Cardiovascular Surgery, vol. 55, no. 6, pp. 266–269, 2007. View at Publisher · View at Google Scholar
  38. Ö. Solak, F. Fidan, Ü. Dündar, et al., “The prevalence of obstructive sleep apnoea syndrome in ankylosing spondylitis patients,” Rheumatology, vol. 48, no. 4, pp. 433–435, 2009. View at Publisher · View at Google Scholar · View at PubMed
  39. S. Garrett, T. Jenkinson, L. G. Kennedy, H. Whitelock, P. Gaisford, and A. Calin, “A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index,” Journal of Rheumatology, vol. 21, no. 12, pp. 2286–2291, 1994.
  40. N. Erb, D. Karokis, J. P. Delamere, M. J. Cushley, and G. D. Kitas, “Obstructive sleep apnoea as a cause of fatigue in ankylosing spondylitis,” Annals of the Rheumatic Diseases, vol. 62, no. 2, pp. 183–184, 2003. View at Publisher · View at Google Scholar
  41. A. Deodhar, J. Braun, R. D. Inman, et al., “Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebo-controlled trial,” Arthritis Care & Research, vol. 62, no. 9, pp. 1266–1271, 2010.
  42. M. Rudwaleit, K. Gooch, B. Michel, et al., “Adalimumab improves sleep and sleep quality in patients with active ankylosing spondylitis,” The Journal of Rheumatology, vol. 38, no. 1, pp. 79–86, 2011.
  43. D. van der Heijde, A. Kivitz, M. H. Schiff et al., “Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial,” Arthritis and Rheumatism, vol. 54, no. 7, pp. 2136–2146, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. R. D. Inman, J. C. Davis, D. Van Der Heijde et al., “Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial,” Arthritis and Rheumatism, vol. 58, no. 11, pp. 3402–3412, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus